Skip to main content
Top
Published in: Medical Oncology 4/2014

01-04-2014 | Original Paper

miR-96 promotes cell proliferation and clonogenicity by down-regulating of FOXO1 in prostate cancer cells

Authors: Jun-Jie Yu, Yin-Xia Wu, Fu-Jun Zhao, Shu-Jie Xia

Published in: Medical Oncology | Issue 4/2014

Login to get access

Abstract

The present study aimed to investigate the biological functions of miR-96 in the processes of proliferation and clonogenicity in the prostate cancer cells. miR-96 was identified to be markedly up-regulated in prostate cancer cell and cancer tissues compared with normal prostate cell and normal prostate tissues by microarray method and RT-PCR analysis. Down-regulation of miR-96 expression reduced the proliferation and colony formation ability of PC3 prostate cancer cells, while over-expression of miR-96 induced proliferation and colony formation ability of LNCaP prostate cancer cells. Forkhead box protein O1 (FOXO1) is key tumor suppressors and has been shown to play key roles in the regulation of diverse cellular processes, including cell proliferation, differentiation, cell cycle progression and apoptosis. The expression level of FOXO1 was strikingly up-regulated in PC3 cells after transfected with miR-96 inhibitor, and FOXO1 expression was down-regulated in LNCaP cells after transfected with miR-96 mimics. miR-96 may play a vital role in promoting cell proliferation in human prostate cancer cells. Inhibition of miR-96 caused expression increase of tumor suppressor gene FOXO1, thus manipulating miR-96 expression may be a promising approach in treatment of prostate cancer.
Literature
1.
go back to reference Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56(2):106–30.PubMedCrossRef Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56(2):106–30.PubMedCrossRef
4.
6.
go back to reference Shi XB, Tepper CG, deVere White RW. Cancerous miRNAs and their regulation. Cell Cycle. 2008;7(11):1529–38.PubMedCrossRef Shi XB, Tepper CG, deVere White RW. Cancerous miRNAs and their regulation. Cell Cycle. 2008;7(11):1529–38.PubMedCrossRef
11.
go back to reference Fletcher CE, Dart DA, Sita-Lumsden A, Cheng H, Rennie PS, Bevan CL. Androgen-regulated processing of the oncomir MiR-27a, which targets Prohibitin in prostate cancer. Hum Mol Genet. 2012;. doi:10.1093/hmg/dds139. Fletcher CE, Dart DA, Sita-Lumsden A, Cheng H, Rennie PS, Bevan CL. Androgen-regulated processing of the oncomir MiR-27a, which targets Prohibitin in prostate cancer. Hum Mol Genet. 2012;. doi:10.​1093/​hmg/​dds139.
14.
go back to reference Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, et al. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer. 2010;126(5):1166–76. doi:10.1002/ijc.24827.PubMed Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, et al. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma. Int J Cancer. 2010;126(5):1166–76. doi:10.​1002/​ijc.​24827.PubMed
15.
go back to reference Larne O, Martens-Uzunova E, Hagman Z, Edsjo A, Lippolis G, den Berg MS, et al. miQ—a novel microRNA based diagnostic and prognostic tool for prostate cancer. Int J Cancer. 2013;132(12):2867–75. doi:10.1002/ijc.27973.PubMedCrossRef Larne O, Martens-Uzunova E, Hagman Z, Edsjo A, Lippolis G, den Berg MS, et al. miQ—a novel microRNA based diagnostic and prognostic tool for prostate cancer. Int J Cancer. 2013;132(12):2867–75. doi:10.​1002/​ijc.​27973.PubMedCrossRef
26.
go back to reference Wu Z, He B, He J, Mao X. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer. Prostate. 2012;. doi:10.1002/pros.22600. Wu Z, He B, He J, Mao X. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer. Prostate. 2012;. doi:10.​1002/​pros.​22600.
Metadata
Title
miR-96 promotes cell proliferation and clonogenicity by down-regulating of FOXO1 in prostate cancer cells
Authors
Jun-Jie Yu
Yin-Xia Wu
Fu-Jun Zhao
Shu-Jie Xia
Publication date
01-04-2014
Publisher
Springer US
Published in
Medical Oncology / Issue 4/2014
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-014-0910-y

Other articles of this Issue 4/2014

Medical Oncology 4/2014 Go to the issue